136 related articles for article (PubMed ID: 7629232)
1. Skeletal muscle proteolysis is reduced in noninsulin-dependent diabetes mellitus and is unaltered by euglycemic hyperinsulinemia or intensive insulin therapy.
Denne SC; Brechtel G; Johnson A; Liechty EA; Baron AD
J Clin Endocrinol Metab; 1995 Aug; 80(8):2371-7. PubMed ID: 7629232
[TBL] [Abstract][Full Text] [Related]
2. Proteolysis in skeletal muscle and whole body in response to euglycemic hyperinsulinemia in normal adults.
Denne SC; Liechty EA; Liu YM; Brechtel G; Baron AD
Am J Physiol; 1991 Dec; 261(6 Pt 1):E809-14. PubMed ID: 1767841
[TBL] [Abstract][Full Text] [Related]
3. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training.
Dela F; Larsen JJ; Mikines KJ; Ploug T; Petersen LN; Galbo H
Diabetes; 1995 Sep; 44(9):1010-20. PubMed ID: 7657022
[TBL] [Abstract][Full Text] [Related]
4. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
Halberstam M; Cohen N; Shlimovich P; Rossetti L; Shamoon H
Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019
[TBL] [Abstract][Full Text] [Related]
5. Intracellular glucose and fat metabolism in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): acquired versus genetic metabolic defects?
Vaag A; Alford F; Beck-Nielsen H
Diabet Med; 1996 Sep; 13(9):806-15. PubMed ID: 8891456
[TBL] [Abstract][Full Text] [Related]
6. Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients.
Kelley DE; Mokan M; Mandarino LJ
Diabetes Care; 1993 Aug; 16(8):1158-66. PubMed ID: 8375246
[TBL] [Abstract][Full Text] [Related]
7. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM.
Zierath JR; He L; Gumà A; Odegoard Wahlström E; Klip A; Wallberg-Henriksson H
Diabetologia; 1996 Oct; 39(10):1180-9. PubMed ID: 8897005
[TBL] [Abstract][Full Text] [Related]
8. Increased glutamine:fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM.
Yki-Järvinen H; Daniels MC; Virkamäki A; Mäkimattila S; DeFronzo RA; McClain D
Diabetes; 1996 Mar; 45(3):302-7. PubMed ID: 8593934
[TBL] [Abstract][Full Text] [Related]
9. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM.
Bonadonna RC; Del Prato S; Bonora E; Saccomani MP; Gulli G; Natali A; Frascerra S; Pecori N; Ferrannini E; Bier D; Cobelli C; DeFronzo RA
Diabetes; 1996 Jul; 45(7):915-25. PubMed ID: 8666143
[TBL] [Abstract][Full Text] [Related]
10. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM.
Laakso M; Edelman SV; Brechtel G; Baron AD
Diabetes; 1992 Sep; 41(9):1076-83. PubMed ID: 1499861
[TBL] [Abstract][Full Text] [Related]
11. Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapy.
Baron AD; Laakso M; Brechtel G; Edelman SV
J Clin Invest; 1991 Apr; 87(4):1186-94. PubMed ID: 2010535
[TBL] [Abstract][Full Text] [Related]
12. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.
Cusi K; Consoli A; DeFronzo RA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4059-67. PubMed ID: 8923861
[TBL] [Abstract][Full Text] [Related]
13. Elevation of serum insulin concentration during euglycemic hyperinsulinemic clamp studies leads to similar activation of insulin receptor kinase in skeletal muscle of subjects with and without NIDDM.
Klein HH; Vestergaard H; Kotzke G; Pedersen O
Diabetes; 1995 Nov; 44(11):1310-7. PubMed ID: 7589829
[TBL] [Abstract][Full Text] [Related]
14. Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM.
Luzi L; Petrides AS; De Fronzo RA
Diabetes; 1993 Dec; 42(12):1868-77. PubMed ID: 8243833
[TBL] [Abstract][Full Text] [Related]
15. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM.
Mandarino LJ; Consoli A; Jain A; Kelley DE
Am J Physiol; 1996 Mar; 270(3 Pt 1):E463-70. PubMed ID: 8638694
[TBL] [Abstract][Full Text] [Related]
16. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
[TBL] [Abstract][Full Text] [Related]
17. Alterations in glucose metabolism in the elderly patient with diabetes.
Meneilly GS; Dawson K; Tessier D
Diabetes Care; 1993 Sep; 16(9):1241-8. PubMed ID: 8404427
[TBL] [Abstract][Full Text] [Related]
18. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
Chung JW; Suh KI; Joyce M; Ditzler T; Henry RR
Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
[TBL] [Abstract][Full Text] [Related]
19. Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulin-dependent diabetes mellitus subjects.
Ciaraldi TP; Abrams L; Nikoulina S; Mudaliar S; Henry RR
J Clin Invest; 1995 Dec; 96(6):2820-7. PubMed ID: 8675652
[TBL] [Abstract][Full Text] [Related]
20. Effects of insulin on vascular tone and sympathetic nervous system in NIDDM.
Tack CJ; Smits P; Willemsen JJ; Lenders JW; Thien T; Lutterman JA
Diabetes; 1996 Jan; 45(1):15-22. PubMed ID: 8522054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
